You are here

  • Home
  • Online First
  • European Network of Gynaecological Oncological Trial Groups’ requirements for trials between academic groupsand industry partners – a new Model D for drug and medical device development

Article Text

Article menu

other Versions

Download PDFPDF
Society statement
European Network of Gynaecological Oncological Trial Groups’ requirements for trials between academic groupsand industry partners – a new Model D for drug and medical device development

https://doi.org/10.1136/ijgc-2020-001464

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Collaborators European Network of Gynaecological Oncological Trial Groups (ENGOT)

    • Contributors All authors were actively involved in the development of the new Model D of cooperation between ENGOT and industry partners and in writing of the manuscript. This process involved two physical meetings, teleconferences, and email communication. All authors agreed to be accountable for all aspects of the work and approved the manuscript for submission.

    • Funding This document is part of the “Gynocare” action, financed by The European Cooperation in Science and Technology (COST), grant action Ca18117.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.